mTNBC Unicorns: Living In Contradiction
MBC Patients, Living with MBC, Challenges and Barriers, Difficult to Treat, Making Our Best MBC Life Our MBClife MBC Patients, Living with MBC, Challenges and Barriers, Difficult to Treat, Making Our Best MBC Life Our MBClife

mTNBC Unicorns: Living In Contradiction

Becoming a cancer “unicorn”--a person whose cancer responds exceptionally well to available treatment and who survives beyond what is expected--is what most of us hope for. This is all the more true for triple negative MBC where effective, targeted treatments are still sorely lacking. Today we talk to two women who have lived with triple negative metastatic breast cancer for 8 years. Dr. Toni Willis and Colleen Broughton share their diagnosis & treatment stories, including their experiences with second opinions, clinical trials, self-advocacy, and cultivating joy for themselves & their families as they navigate surviving longer than they –or their doctors—expected to.

Read More
ER Progression and Resistance: Causes, Consequences, and Hope
Novel Treatments, Obstacles to Better Outcomes, Medical Community, Entities of Cancer, Difficult to Treat, Clinical Research, Precision Oncology, MBC Imaging and Profiling, Translational Research, Basic Science, Diagnosis and Treatment, Patient Reported Outcomes and Out of the Box Treatment Options Our MBClife Novel Treatments, Obstacles to Better Outcomes, Medical Community, Entities of Cancer, Difficult to Treat, Clinical Research, Precision Oncology, MBC Imaging and Profiling, Translational Research, Basic Science, Diagnosis and Treatment, Patient Reported Outcomes and Out of the Box Treatment Options Our MBClife

ER Progression and Resistance: Causes, Consequences, and Hope

Endocrine therapy is an effective way to treat hormone-sensitive breast cancers, but de novo and acquired resistance to this treatment remains a major challenge. In this episode, the Our MBC Life team hears from two dynamic MSK oncologists Dr. Pedram Razavi and Dr. Komal Jhaveri on treatment strategies and the latest research around the problem of endocrine resistance.

Read More
Report Back from SABCS 2021: What’s the Latest in MBC Research?
Novel Treatments, Medical Community, Diagnosis and Treatment, Updates from Conferences, Radiation Therapy, Immunotherapy, Difficult to Treat, Clinical Research, Translational Research, Entities of Cancer Our MBClife Novel Treatments, Medical Community, Diagnosis and Treatment, Updates from Conferences, Radiation Therapy, Immunotherapy, Difficult to Treat, Clinical Research, Translational Research, Entities of Cancer Our MBClife

Report Back from SABCS 2021: What’s the Latest in MBC Research?

Learn about the most recent information released at the annual San Antonio Breast Cancer Symposium regarding metastatic breast cancer research with Dr. Peter Schmid, Professor of Cancer Medicine at Barts Cancer Institute in London, England. Dr. Schmid will provide a comprehensive update and answer your questions about these new developments.

Read More
Road to a Cure - use of immunotherapy
Immunotherapy, MBC Stories, Patient Advocates, Novel Treatments, Medical Community, Challenges and Barriers, Clinical Trials Process, Difficult to Treat, Obstacles to Better Outcomes, Entities of Cancer, MBC Imaging and Profiling Our MBClife Immunotherapy, MBC Stories, Patient Advocates, Novel Treatments, Medical Community, Challenges and Barriers, Clinical Trials Process, Difficult to Treat, Obstacles to Better Outcomes, Entities of Cancer, MBC Imaging and Profiling Our MBClife

Road to a Cure - use of immunotherapy

This week we are visiting Dr Stephanie Goff at the NIH in Bethesda, Maryland. Dr Goff is a surgical oncologist and a senior member of a research team led by Dr. Steven A. Rosenberg, a man widely regarded as the father of immunotherapy. A friend, who knows a thing or two about this place. is joining us on this trip. Her name is Judy Perkins, and she is the first MBC patient who has been cured by a revolutionary immunotherapy treatment, known as adoptive cell therapy, that was administered by Dr Goff and her colleagues at the NCI.

Read More
Report Back from ASCO: What’s the Latest in Metastatic Breast Cancer
Novel Treatments, Medical Community, Clinical Research, Entities of Cancer, Updates from Conferences, Difficult to Treat, Obstacles to Better Outcomes Our MBClife Novel Treatments, Medical Community, Clinical Research, Entities of Cancer, Updates from Conferences, Difficult to Treat, Obstacles to Better Outcomes Our MBClife

Report Back from ASCO: What’s the Latest in Metastatic Breast Cancer

Are you living with ER+/HER2- or TNBC MBC and tired of hearing about new HER2 therapies and wondering when it will be your turn? Just after the meeting SHARE welcomed Dr. Timothy Pluard from University of Missouri-KC School of Medicine to a webinar highlighting promising data from trials and labs across the globe presented at the this year’s meeting,

Read More
What Cancer Patients Need to Know About COVID-19 Vaccines
Living with MBC, MBC Allies, Clinical Trials Process Our MBClife Living with MBC, MBC Allies, Clinical Trials Process Our MBClife

What Cancer Patients Need to Know About COVID-19 Vaccines

Welcome to this bonus episode of Our MBC Life. We are pleased to again highlight a program from our parent non-profit SHARE Cancer Support.

For many of us living with cancer there are numerous questions about COVID-19, the vaccines, and what we need to know to best take care of ourselves.

On February 11 SHARE invited Dr. Joshua Hill from Fred Hutchinson Research Center to discuss the COVID-19 Vaccine in relation to cancer patients and their treatment

Read More
Report back from SABCS
Medical Community, Clinical Research, Lifestyle Research, Diagnosis and Treatment, Updates from Conferences, Entities of Cancer, Novel Treatments, Obstacles to Better Outcomes, Difficult to Treat, MBC Imaging and Profiling Our MBClife Medical Community, Clinical Research, Lifestyle Research, Diagnosis and Treatment, Updates from Conferences, Entities of Cancer, Novel Treatments, Obstacles to Better Outcomes, Difficult to Treat, MBC Imaging and Profiling Our MBClife

Report back from SABCS

Welcome to this bonus episode of Our MBC Life. It feels like a lifetime ago, but just a few weeks ago the world's largest breast cancer conference, the San Antonio Breast Cancer Symposium, was held. Just after the symposium SHARE welcomed Dr. Neil Iyengar from Memorial Sloan Kettering to a webinar where he shared information from SABCS highlighting both early-stage and metastatic research.

Read More